Enhancement of CD4 and CD8 Immunity by Anti-Cd137 (4-1bb) Monoclonal Antibodies During Hepatitis C Vaccination With Recombinant Adenovirus

Vaccine - Netherlands
doi 10.1016/j.vaccine.2005.02.003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Antibodies to Costimulatory Receptor 4-1bb Enhance Anti-Tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function

Immunity
Infectious DiseasesAllergyImmunology
2018English

Cancer Immunotherapy With Immunomodulatory Anti-Cd137 and Anti-Pd-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells

Cancer Discovery
Oncology
2015English

CD137 (4-1bb) Deficiency Reduces Atherosclerosis in Hyperlipidemic Mice

Circulation
Cardiovascular MedicinePhysiologyCardiology
2010English

CD4+ and CD8+ T Cell Activation in Children With Hepatitis C

Journal of Pediatrics
Child HealthPediatricsPerinatology
2016English

TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination With Anti-Pd1 and Anti-Cd137 Immunostimulatory Monoclonal Antibodies

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

Hepatitis C Virus Adaptations to Altered CD8+ T-Cell Immunity During Pregnancy

Future Virology
Virology
2014English

Monoclonal Anti-Claudin 1 Antibodies Prevent Hepatitis C Virus Infection of Primary Human Hepatocytes

Gastroenterology
HepatologyGastroenterology
2010English

4-1bb (CD137) Ligand Enhanced Anti-Tumor Immune Response Against Mouse Forestomach Carcinoma in Vivo

Cellular and Molecular Immunology
Infectious DiseasesMedicineAllergyImmunology
2008English

Fc-Engineered Anti-4-1bb Antibodies Pack a One-Two Punch

Immunity
Infectious DiseasesAllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy